MGO One Seven’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.9M | Buy |
86,988
+2,549
| +3% | +$565K | 0.38% | 45 |
|
|
2025
Q4 | $19.3M | Buy |
84,439
+7,346
| +10% | +$1.67M | 0.39% | 41 |
|
|
2025
Q3 | $17.9M | Buy |
77,093
+50,303
| +188% | +$10.2M | 0.41% | 44 |
|
|
2025
Q2 | $4.97M | Sell |
26,790
-764
| -3% | -$142K | 0.16% | 137 |
|
|
2025
Q1 | $5.77M | Buy |
27,554
+2,637
| +11% | +$513K | 0.22% | 104 |
|
|
2024
Q4 | $4.43M | Sell |
24,917
-1,793
| -7% | -$330K | 0.17% | 132 |
|
|
2024
Q3 | $5.27M | Sell |
26,710
-1,915
| -7% | -$357K | 0.23% | 107 |
|
|
2024
Q2 | $4.91M | Buy |
28,625
+2,589
| +10% | +$429K | 0.23% | 103 |
|
|
2024
Q1 | $4.74M | Sell |
26,036
-967
| -4% | -$167K | 0.25% | 98 |
|
|
2023
Q4 | $4.18M | Buy |
27,003
+3,868
| +17% | +$564K | 0.24% | 103 |
|
|
2023
Q3 | $3.45M | Sell |
23,135
-2,375
| -9% | -$349K | 0.27% | 91 |
|
|
2023
Q2 | $3.44M | Sell |
25,510
-18,200
| -42% | -$2.67M | 0.31% | 68 |
|
|
2023
Q1 | $6.97M | Buy |
43,710
+18,926
| +76% | +$2.89M | 0.44% | 46 |
|
|
2022
Q4 | $4.01M | Buy |
24,784
+4,042
| +19% | +$620K | 0.4% | 53 |
|
|
2022
Q3 | $3.42K | Buy |
20,742
+718
| +4% | +$103K | 0.13% | 103 |
|
|
2022
Q2 | $3.07M | Sell |
20,024
-1,089
| -5% | -$166K | 0.42% | 51 |
|
|
2022
Q1 | $3.42M | Buy |
21,113
+1,465
| +7% | +$213K | 0.37% | 63 |
|
|
2021
Q4 | $2.66M | Buy |
19,648
+10,651
| +118% | +$1.26M | 0.28% | 87 |
|
|
2021
Q3 | $1.03M | Sell |
8,997
-5,578
| -38% | -$637K | 0.13% | 193 |
|
|
2021
Q2 | $1.64M | Buy |
14,575
+397
| +3% | +$44.7K | 0.23% | 117 |
|
|
2021
Q1 | $1.53M | Buy |
14,178
+1,905
| +16% | +$204K | 0.26% | 94 |
|
|
2020
Q4 | $1.31M | Buy |
12,273
+574
| +5% | +$55.2K | 0.27% | 91 |
|
|
2020
Q3 | $1.02M | Buy |
11,699
+968
| +9% | +$91.1K | 0.24% | 100 |
|
|
2020
Q2 | $1.05M | Buy |
10,731
+4,590
| +75% | +$404K | 0.27% | 95 |
|
|
2020
Q1 | $467K | Buy |
6,141
+858
| +16% | +$73.1K | 0.16% | 185 |
|
|
2019
Q4 | $467K | Buy |
5,283
+2,261
| +75% | +$188K | 0.12% | 231 |
|
|
2019
Q3 | $229K | Buy |
+3,022
| New | +$207K | 0.07% | 369 |
|
|
2019
Q1 | – | Sell |
-2,096
| Closed | -$192K | – | 425 |
|
|
2018
Q4 | $192K | Buy |
+2,096
| New | +$184K | 0.08% | 273 |
|
|
2018
Q1 | $148K | Buy |
1,566
+34
| +2% | +$3.73K | 0.07% | 332 |
|
|
2017
Q4 | $148K | Buy |
+1,532
| New | +$144K | 0.07% | 333 |
|
Other funds holding ABBV
VCM
VPM
MGO One Seven's ABBV Position: Q1 2026 in Review
MGO One Seven increased its AbbVie (ABBV) stake by 3% in Q1 2026, buying an estimated $565K and bringing the position to 86,988 shares worth $18.9M. The position accounts for 0.38% of the portfolio, ranked #45.
MGO One Seven first reported a position in ABBV in Q4 2017 and has held it in 30 quarters since. The position peaked at $19.3M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- MGO One Seven held 86,988 shares of AbbVie worth $18.9M as of Q1 2026.
- MGO One Seven bought 2,549 AbbVie shares in Q1 2026, an estimated $565K.
- AbbVie made up 0.38% of MGO One Seven's portfolio in Q1 2026, its #45 holding.
- MGO One Seven first reported a position in AbbVie in Q4 2017 and has held it in 30 quarters since.
- MGO One Seven's AbbVie position peaked at $19.3M in Q4 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on MGO One Seven's 13F filing for Q1 2026, filed 14 May 2026.